卵巢边界血清性瘤中的埃索诺菲尔细胞作为BRAF突变的预测因子

Alina Badlaeva1, Anna Tregubova1, Andrea Palicelli2

  • 1National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of the Ministry of Health of Russia, Bldg. 4, Oparina Street, 117513 Moscow, Russia.

Cancers
|July 13, 2024
PubMed
概括

卵巢血清边缘性瘤 (SBTs) 中的异性细胞 (ECs) 可能表明BRAF V600E突变,这表明进展风险较低. 这一发现可能会导致EC作为SBTs中这种突变的主要查测试.